Subclonal MECOM rearrangements in myeloid neoplasms: enriched for TP53 mutations and adverse outcome.

Eckfeld Eckfeld, Stengel Stengel, Huber Huber, Prohaska Prohaska, Meggendorfer Meggendorfer, Haferlach Haferlach, Summerer Summerer